FOLH1 and prostate carcinoma: In vitro, prostate carcinoma cells expressing PSMA grown in the presence of polyglutamate folate were shown to have a significantly higher proliferation rate when compared to PSMA-negative cells, which could be attenuated by the PSMA-specific inhibitor 2-PMPA [25,26,27,28,29].